AbCellera Biologics Inc. (ABCL)

NASDAQ: ABCL · Real-Time Price · USD

10.97

+0.61 (5.89%)

At close: Aug 13, 2026, 4:00 PM EDT

10.96

-0.01 (-0.09%)

After-hours: Aug 13, 2026, 7:59 PM EDT

AbCellera Biologics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	66.17	75.13	28.83	38.03	485.42	375.2
Revenue Growth	101.28%	160.56%	-24.17%	-92.17%	29.38%	60.92%
Gross Profit	66.17	75.13	28.83	38.03	485.42	375.2
Selling, General & Admin	68.36	83.23	85.49	75.18	66.76	48.76
Depreciation & Amortization Expenses	25.2	22.17	90.85	24.4	27.84	14.45
Research & Development	197.77	186.83	167.26	175.66	107.88	62.06
Other Operating Expenses	-	-	-	-	66.44	45.52
Total Operating Expenses	291.33	292.23	343.6	275.23	268.91	170.79
Operating Income	-225.16	-217.1	-314.77	-237.21	216.51	204.41
Interest Income	12.69	28.33	38.47	42.25	16.08	3.33
Other Non-Operating Income (Expense)	8.5	11.18	75.9	20.93	6.51	11.41
Total Non-Operating Income (Expense)	21.19	39.51	114.37	63.18	22.59	14.74
Pretax Income	-196.77	-177.6	-200.4	-174.03	239.1	219.15
Provision for Income Taxes	-32.11	-31.18	-37.54	-27.63	80.58	65.69
Net Income	-164.66	-146.41	-162.86	-146.4	158.52	153.46
Net Income to Common	-164.66	-146.41	-162.86	-146.4	158.52	153.46
Net Income Growth	-	-	-	-	3.29%	29.05%
Shares Outstanding (Basic)	302	299	294	289	285	276
Shares Outstanding (Diluted)	302	299	294	289	315	318
Shares Change	1.74%	1.49%	1.79%	-8.15%	-1.09%	20.96%
EPS (Basic)	-0.54	-0.49	-0.55	-0.51	0.56	0.56
EPS (Diluted)	-0.54	-0.49	-0.55	-0.51	0.50	0.48
EPS Growth	-	-	-	-	4.17%	6.67%

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-119.67	-174.07	-186.95	-120.82	206.7	186.13
Free Cash Flow Growth	-	-	-	-	11.05%	1329.91%
Free Cash Flow Per Share	-0.40	-0.58	-0.64	-0.42	0.66	0.58
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	-340.25%	-288.98%	-1091.69%	-623.82%	44.60%	54.48%
Profit Margin	-248.83%	-194.88%	-564.83%	-385.00%	32.66%	40.90%
FCF Margin	-180.85%	-231.69%	-648.40%	-317.75%	42.58%	49.61%
EBITDA	-192.56	-188.28	-217.77	-206.31	249.61	221.66
EBITDA Margin	-291.00%	-250.61%	-755.27%	-542.57%	51.42%	59.08%
EBIT	-225.16	-217.1	-314.77	-237.21	216.51	204.41
EBIT Margin	-340.25%	-288.98%	-1091.69%	-623.82%	44.60%	54.48%
Effective Tax Rate	16.32%	17.56%	18.73%	15.88%	33.70%	29.97%

SEC Filings: 10-K · 10-Q